Workflow
瑞生医疗全球研发中心落户东方眼谷
Chang Sha Wan Bao·2025-08-29 03:57

Core Insights - The establishment of the global R&D center by Ruisheng Medical in Changsha marks a significant milestone in the company's development, focusing on key technological advancements in the ophthalmology industry [1][3][4] Company Overview - Ruisheng Medical, founded in 2019, is an international eye health technology enterprise that integrates R&D, production, marketing, and services, aiming to provide quality ophthalmic products globally [3][4] - The company specializes in high-value ophthalmic products, including orthokeratology lenses, scleral lenses, artificial lenses, and artificial irises, and has developed several innovative products under its optical brand "Aikeni" [3][4] R&D Center Functionality - The global R&D center is designed as a comprehensive innovation platform that combines basic research, pilot incubation, clinical validation, and industrial transformation, equipped with advanced precision processing workshops for ophthalmic instruments [4][5] - The center aims to leverage China's market resources and innovation environment to produce competitive technologies and products, with expectations to launch multiple core technologies and products with independent intellectual property rights in the next 3 to 5 years [4][5] Industry Impact - The establishment of the R&D center aligns with the urgent need for innovation in the ophthalmology sector, contributing to the development of industry standards and enhancing the quality of eye care services [4][5] - The collaboration with Aier Eye Hospital Group is expected to deepen research efforts and tackle key technological challenges in ophthalmology, ultimately providing better medical services to global eye disease patients [5]